Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High-Resolution PET-CT Imaging for Surgical Margin Visualization

NCT: NCT06915454 · RECRUITING

NCT IDNCT06915454
StatusRECRUITING
Start Date2025-09-03
Completion2027-07

Brief Summary

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are anticipated given the diagnostic and non-invasive, 'ex vivo' nature of device use. Of note, the surgical resection will proceed as per standard of care and will not be affected by the research protocol. Potential Benefit: Imaging intra-operatively will ensure surgeons to identify at risk resection margins. Time Commitment: There are no additional visits that will be asked of you to partake in this study. Drug is FDA approved and Exposure to Radiation is minimal.

Frequently Asked Questions

What is High-Resolution PET-CT Imaging for Surgical Margin Visualization?

High-Resolution PET-CT Imaging for Surgical Margin Visualization is a clinical trial registered under NCT06915454. Current status: RECRUITING.

What is the status of NCT06915454?

The current status of NCT06915454 (High-Resolution PET-CT Imaging for Surgical Margin Visualization) is: RECRUITING.

When did High-Resolution PET-CT Imaging for Surgical Margin Visualization start?

High-Resolution PET-CT Imaging for Surgical Margin Visualization started on 2025-09-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.